Form 4: Omada Health CEO Sells Shares Under 10b5-1 Plan

Omada Health CEO Sean P. Duffy sold 9,266 shares of common stock for $15.3657 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (OMDA), reported a sale of common stock.
• The transaction involved the disposition of 9,266 shares of Omada Health common stock.
• The shares were sold at a weighted average price of $15.3657 per share, with trades ranging from $15.24 to $15.51.
• The total value of the transaction was approximately $142,470.
• The sale occurred on December 10, 2025, and was executed pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025.
• Following this transaction, Mr. Duffy directly holds 126,644 shares of common stock.
• Additionally, 861,109 shares are held indirectly in family trusts, for which Mr. Duffy disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. This type of transaction is generally considered neutral as it is planned in advance and not typically indicative of new material information or a change in management's outlook on the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This insider transaction is a routine disclosure for a public company executive and does not inherently reflect broader industry trends or competitive positioning. Such sales under 10b5-1 plans are common for executives managing personal liquidity and diversification.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a pre-scheduled and routine insider sale, not typically signaling a change in company fundamentals or management's confidence.

Key Dates

Keywords

Omada Health, OMDA, Sean Duffy, CEO, Insider Trading, Stock Sale, 10b5-1 Plan, Beneficial Ownership